ES484149A1 - Procedimiento para la preparacion de un derivado de tiadia- zol - Google Patents

Procedimiento para la preparacion de un derivado de tiadia- zol

Info

Publication number
ES484149A1
ES484149A1 ES484149A ES484149A ES484149A1 ES 484149 A1 ES484149 A1 ES 484149A1 ES 484149 A ES484149 A ES 484149A ES 484149 A ES484149 A ES 484149A ES 484149 A1 ES484149 A1 ES 484149A1
Authority
ES
Spain
Prior art keywords
alkyl
antisecretory
manufacture
processes
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES484149A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Zeneca Inc
Original Assignee
Imperial Chemical Industries Ltd
ICI Americas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd, ICI Americas Inc filed Critical Imperial Chemical Industries Ltd
Publication of ES484149A1 publication Critical patent/ES484149A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Procedimiento para la preparación de un derivado de tiadiazol. El procedimiento de la invención puede efectuarse empleando un exceso de metilamina, preferentemente en presencia de un diluyente o un disolvente tal como agua, metanol o etanol o una mezcla de cualquiera de dos de ellos. Un procedimiento preferido emplea una solución al 33% p/v de metilamina en etanol o una solución al 40% p/p de metilamina en agua. Alternativamente puede hacerse pasar una corriente de metilamina gaseosa a través de la suspensión agitada del compuesto de fórmula II en etanol. R1 es preferentemente un radical alcoxi o alquiltio, por ejemplo, un radical metoxi, etoxi o metilito. El radical metoxi es particularmente preferido.
ES484149A 1978-05-24 1979-09-13 Procedimiento para la preparacion de un derivado de tiadia- zol Expired ES484149A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2173778 1978-05-24

Publications (1)

Publication Number Publication Date
ES484149A1 true ES484149A1 (es) 1980-04-16

Family

ID=10167957

Family Applications (3)

Application Number Title Priority Date Filing Date
ES480894A Expired ES480894A1 (es) 1978-05-24 1979-05-24 Procedimiento para la preparacion de derivados de tiadiazol.
ES484150A Expired ES484150A1 (es) 1978-05-24 1979-09-13 Procedimiento para la preparacion de derivados de tiadiazol
ES484149A Expired ES484149A1 (es) 1978-05-24 1979-09-13 Procedimiento para la preparacion de un derivado de tiadia- zol

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES480894A Expired ES480894A1 (es) 1978-05-24 1979-05-24 Procedimiento para la preparacion de derivados de tiadiazol.
ES484150A Expired ES484150A1 (es) 1978-05-24 1979-09-13 Procedimiento para la preparacion de derivados de tiadiazol

Country Status (22)

Country Link
US (2) US4242350A (es)
EP (1) EP0006679B1 (es)
JP (1) JPS54160376A (es)
AT (1) ATE1353T1 (es)
AU (1) AU529253B2 (es)
CA (1) CA1124729A (es)
CS (2) CS207790B2 (es)
DD (1) DD143772A5 (es)
DE (1) DE2963363D1 (es)
DK (1) DK209079A (es)
ES (3) ES480894A1 (es)
FI (1) FI791656A (es)
GR (1) GR73611B (es)
HU (1) HU179492B (es)
IE (1) IE48221B1 (es)
IL (1) IL57388A0 (es)
NO (1) NO791710L (es)
NZ (1) NZ190448A (es)
PL (1) PL118387B1 (es)
PT (1) PT69651A (es)
SU (1) SU1037839A3 (es)
ZA (1) ZA792202B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006679B1 (en) * 1978-05-24 1982-07-21 Imperial Chemical Industries Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
DE3069889D1 (en) * 1979-01-18 1985-02-14 Ici Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
GR71929B (es) * 1979-11-13 1983-08-19 Ici Ltd
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
DE3270716D1 (en) * 1981-02-27 1986-05-28 Ici Plc Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
CA1209998A (en) * 1981-03-09 1986-08-19 David J. Gilman Amide derivatives as histamine h-2 receptor antagonists
US4460584A (en) * 1981-03-13 1984-07-17 Imperial Chemical Industries Plc Nitrogen heterocycles
IN158869B (es) * 1981-03-18 1987-02-07 Ici Plc
US4463005A (en) * 1981-03-18 1984-07-31 Imperial Chemical Industries Plc Bicyclic guanidines
US4451463A (en) * 1981-03-24 1984-05-29 Imperial Chemical Industries Plc Alcohol derivatives
EP0065823A1 (en) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterocyclic guanidines as histamine H-2 antagonists
US4539316A (en) * 1981-05-18 1985-09-03 Bristol-Myers Company Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones
US4526973A (en) * 1981-05-18 1985-07-02 Bristol-Myers Company Chemical compounds
US4522943A (en) * 1981-05-18 1985-06-11 Bristol-Myers Company Chemical compounds
US4390701A (en) * 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
DE3267110D1 (de) * 1981-05-18 1985-12-05 Ici Plc Amidine derivatives
US4607105A (en) * 1981-05-18 1986-08-19 Bristol-Myers Company 3-cyclobutene-1,2-dione intermediates
US4546188A (en) * 1981-05-18 1985-10-08 Bristol-Myers Company Substituted 1,2-diaminocyclobutene-3,4-diones
US4395553A (en) * 1981-05-18 1983-07-26 Bristol-Myers Company Chemical compounds
GB8419223D0 (en) * 1984-07-27 1984-08-30 Hoechst Uk Ltd Sulphamoylguanidine derivatives
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE842346C (de) * 1950-10-14 1952-06-26 Joachim Dipl-Chem Dr Goerdeler Verfahren zur Darstellung von 5-Amino-1, 2, 4-thiodiazolen
DE955684C (de) * 1953-10-14 1957-01-10 Bayer Ag Verfahren zur Herstellung von 5-Amino-1, 2, 4-thiodiazolen
NL266116A (es) 1960-06-22
GB1305549A (es) 1969-10-29 1973-02-07
BE758146A (fr) 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
GB1338169A (en) 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1400319A (en) 1972-04-20 1975-07-16 Smith Kline French Lab Pharmaceutical compositions
GB1397436A (en) 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1398426A (en) 1972-09-05 1975-06-18 Smith Kline French Lab Heterocyclic substituted guanidines
GB1421999A (en) 1973-02-08 1976-01-21 Smith Kline French Lab Heterocyclic containing sulphoxides
GB1419994A (en) 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
GB1421792A (en) 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
GB1497260A (en) 1974-06-28 1978-01-05 Smith Kline French Lab Guanidine derivatives
GB1533380A (en) 1974-09-02 1978-11-22 Smith Kline French Lab Process for the preparation of heterocyclic substituted thioureas and h-cyanoguanidines
GB1531231A (en) 1974-09-02 1978-11-08 Smith Kline French Lab Process for the production of cyanoguanidine derivatives
GB1533379A (en) 1974-09-02 1978-11-22 Smith Kline French Lab Process for the preparation of heterocyclic substituted ureas
GB1574214A (en) 1976-03-11 1980-09-03 Smith Kline French Lab Amidines
IE47044B1 (en) * 1977-04-20 1983-12-14 Ici Ltd Guanidine derivatives
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
EP0006679B1 (en) * 1978-05-24 1982-07-21 Imperial Chemical Industries Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IE48221B1 (en) 1984-10-31
PT69651A (en) 1979-06-01
ES484150A1 (es) 1980-04-16
US4332949A (en) 1982-06-01
EP0006679B1 (en) 1982-07-21
GR73611B (es) 1984-03-26
ZA792202B (en) 1980-05-28
NZ190448A (en) 1980-12-19
DK209079A (da) 1979-11-25
AU4711479A (en) 1979-11-29
IE790902L (en) 1979-11-24
EP0006679A1 (en) 1980-01-09
DD143772A5 (de) 1980-09-10
JPS54160376A (en) 1979-12-19
CS207791B2 (en) 1981-08-31
HU179492B (en) 1982-10-28
AU529253B2 (en) 1983-06-02
PL215764A1 (es) 1980-06-16
US4242350A (en) 1980-12-30
PL118387B1 (en) 1981-09-30
ES480894A1 (es) 1980-02-01
FI791656A (fi) 1979-11-25
NO791710L (no) 1979-11-27
SU1037839A3 (ru) 1983-08-23
DE2963363D1 (en) 1982-09-09
CS207790B2 (en) 1981-08-31
IL57388A0 (en) 1979-09-30
ATE1353T1 (de) 1982-08-15
CA1124729A (en) 1982-06-01

Similar Documents

Publication Publication Date Title
ES484150A1 (es) Procedimiento para la preparacion de derivados de tiadiazol
ES477387A1 (es) Procedimiento para preparar derivados de guanidina.
ES8609247A1 (es) Un procedimiento para la preparacion de derivados del indol
HUT40668A (en) Process for preparing new benzoxazole and amine derivatives and pharmaceutical compositions containing such compounds
PH20468A (en) Novel pharmaceutically active di-esters of 3,5-dicarboxy-4-substituted-pyridines and pyrans
GB2001624A (en) Guanidine derivatives
DE2966646D1 (en) Antisecretory branched-chain heterocyclic guanidine derivatives, processes for their manufacture, intermediates, and pharmaceutical compositions containing said derivatives
NO894663D0 (no) Renin-hemmende aminodiolderivater.
ES428535A1 (es) Un procedimiento para la preparacion de cicloserina n-sus- tituida.